About BPL
About Plasma
Therapy Areas
Support Literature
Business Development
Glossary of Terms
Getting in Touch
Home
Therapy Areas - Coagulation Factors

Haemophilia B

Haemophilia B is due to a deficiency of Factor IX. It is also known as Christmas Disease (after the person in whom the disease was first identified). The genetic defect is sex-linked and approximately 1 in 50,000 are affected. If untreated, patients with severe deficiencies may have frequent spontaneous bleeding into joints and muscles; they bleed excessively during minor surgery (e.g. tooth extraction) and may suffer life-threatening bleeding from trauma or even relatively mild injury. Replacement of the missing Factor IX corrects the bleeding problem.

Correlation of Coagulation Factor activity and disease severity
in Haemophilia A and B

Coagulation Factor Activity (% normal) Clinical Manifestation
<2 Severe – frequent spontaneous bleeds from early life, joint deformity and crippling if not adequately treated
2-10 Moderate – post-traumatic bleeding, occasional spontaneous bleeds
>10 Mild – post-traumatic bleeding

 

Patient Information Leaflets (PIL)
Click here to download the documentFactor IX Concentrate - Patient Information Leaflet (PIL)

Site last updated 01/07/2009 10:06:24 © Bio Products Laboratory, 2003 Contact: +44 (0)20 8258 2200 e-mail: info@bpl.co.uk
Terms
Site Map